Literature DB >> 1798293

Reactive oxygen species, antiproteases, and cytokines in sepsis.

A Wendel1.   

Abstract

Although the shock syndrome is recognized as a form of "mediator poisoning", a plethora of details is hardly converging into a coherent concept of chronological and molecular order. As a model for organ failure in septic shock, three alternative experimental approaches with a common pathology are presented: When galactosamine-sensitized mice receive either lipopolysaccharide or leukotriene D4 or tumor necrosis factor alpha they develop fulminant hepatitis within few hours with a lethal outcome within one day. Detailed pharmacological intervention studies allow to conclude that endotoxin-induced leukotriene D4 release induces a transient ischemia by the known vasoconstrictive action of this eicosanoid. A following reperfusion/reoxygenation phase gives rise to superoxide formation which inactivates alpha 1 proteinase inhibitor. Thus a serine protease becomes active which is responsible for the processing of a monocytic tumor necrosis factor alpha precursor to be released into the circulation after proteolytic cleavage. By this sequence the final central mediator of shock and sepsis becomes systematically abundant. The concept arising from these studies reconciles previously known findings and provides a link between the role of reactive oxygen species in inflammation, the balance of proteases and antiproteases in the extracellular space and the release of the cytokine tumor necrosis factor in sepsis and shock.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1798293     DOI: 10.1007/BF01645141

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  18 in total

1.  The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center.

Authors:  D Johnson; J Travis
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

2.  Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized mice.

Authors:  G Tiegs; M Niehörster; A Wendel
Journal:  Biochem Pharmacol       Date:  1990-09-15       Impact factor: 5.858

3.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.

Authors:  M Kriegler; C Perez; K DeFay; I Albert; S D Lu
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

4.  Leukotrienes as mediators of ischemia and shock.

Authors:  A M Lefer
Journal:  Biochem Pharmacol       Date:  1986-01-15       Impact factor: 5.858

5.  Galactosamine-induced sensitization to the lethal effects of endotoxin.

Authors:  C Galanos; M A Freudenberg; W Reutter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

6.  Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action.

Authors:  W Hagmann; C Denzlinger; D Keppler
Journal:  Circ Shock       Date:  1984

7.  Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in mice.

Authors:  A Wendel; G Tiegs; C Werner
Journal:  Biochem Pharmacol       Date:  1987-08-15       Impact factor: 5.858

8.  Leukotriene-mediated liver injury.

Authors:  G Tiegs; A Wendel
Journal:  Biochem Pharmacol       Date:  1988-07-01       Impact factor: 5.858

9.  Effects of leukotrienes and the thromboxane A2 analogue U-46619 in isolated perfused rat liver. Metabolic, hemodynamic and ion-flux responses.

Authors:  D Häussinger; T Stehle; W Gerok
Journal:  Biol Chem Hoppe Seyler       Date:  1988-02

10.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.

Authors:  B Beutler; J Mahoney; N Le Trang; P Pekala; A Cerami
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Immunomodulation by antibacterial agents. Is it clinically relevant?

Authors:  M T Labro
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

2.  Effect of bacterial lipopolysaccharide on the content of lipid peroxidation products in lungs and other organs of mice.

Authors:  D Nowak; T Pietras; A Antczak; M Król; G Piasecka
Journal:  Antonie Van Leeuwenhoek       Date:  1993-01       Impact factor: 2.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.